骨髓增生异常综合征(MDS)/骨髓增殖性疾病(MPD)是一组起源于造血干/祖细胞的异质性、克隆性疾病,兼具骨髓增生异常和慢性骨髓增殖性疾病的双重特点。此类疾病在儿科发病率较低,缺乏统一的诊断分类标准。因此临床工作中,常发生漏诊或误诊。本文根据近年国际上对 Myelodysplastic syndromes (MDSs) / myeloproliferative disorders (MPDs) are a group of heterogeneous, clonal diseases that originate in hematopoietic stem / progenitor cells, both dual myelodysplasia and chronic myeloproliferative disorders. The incidence of such diseases in the pediatric lower, the lack of a unified diagnostic criteria. Therefore, clinical work, often missed diagnosis or misdiagnosis. This article is based on the international right in recent years